Longitudinal monitoring of nanofibrillar cellulose hydrogel medical implants in mice using positron emission tomography

dc.contributor.authorZhuang, Xiaoqing
dc.contributor.authorVirta, Jenni
dc.contributor.authorLiljenbäck, Heidi
dc.contributor.authorPaasonen, Lauri
dc.contributor.authorAiraksinen, Anu J.
dc.contributor.authorRoivainen, Anne
dc.contributor.authorLi, Xiang-Guo
dc.contributor.organizationfi=PET-keskus|en=Turku PET Centre|
dc.contributor.organizationfi=kemian laitos|en=Department of Chemistry|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.14646305228
dc.converis.publication-id505885289
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/505885289
dc.date.accessioned2026-01-21T12:12:56Z
dc.date.available2026-01-21T12:12:56Z
dc.description.abstract<p>Nanofibrillar cellulose (NFC) hydrogel has emerged as a promising implantable material for therapeutic applications. In this study, the relatively longer-lived positron-emitting radionuclide zirconium-89 was chelated to the octadentate deferoxamine (DFO*)-conjugated NFC hydrogel ([<sup>89</sup>Zr]Zr-DFO*-NFC) to enable longitudinal monitoring of its <em>in vivo</em> fate using positron emission tomography techniques. Following subcutaneous implantation in healthy mice, [<sup>89</sup>Zr]Zr-DFO*-NFC retained radioactivity at the implant site for at least 14 days, with minimal signal detected in the kidneys, urinary bladder, and overlying skin. In contrast, mice receiving a control formulation of [<sup>89</sup>Zr]Zr-oxalate mixed with NFC hydrogel showed progressive accumulation of radioactivity in the bones, consistent with known [<sup>89</sup>Zr]Zr-oxalate distribution patterns, and only limited retention at the implant site by Day 7. These findings demonstrate that [<sup>89</sup>Zr]Zr-DFO*-NFC hydrogel implants exhibit high <em>in vivo</em> stability with negligible systemic release following subcutaneous implantation, supporting their potential use as safe and traceable biomaterial platforms.<br></p>
dc.identifier.eissn1879-0720
dc.identifier.jour-issn0928-0987
dc.identifier.olddbid212232
dc.identifier.oldhandle10024/195250
dc.identifier.urihttps://www.utupub.fi/handle/11111/43740
dc.identifier.urlhttps://doi.org/10.1016/j.ejps.2025.107402
dc.identifier.urnURN:NBN:fi-fe202601216672
dc.language.isoen
dc.okm.affiliatedauthorZhuang, Xiaoqing
dc.okm.affiliatedauthorVirta, Jenni
dc.okm.affiliatedauthorLiljenbäck, Heidi
dc.okm.affiliatedauthorAiraksinen, Anu
dc.okm.affiliatedauthorRoivainen, Anne
dc.okm.affiliatedauthorLi, Xiang-Guo
dc.okm.affiliatedauthorDataimport, Kemian laitoksen yhteiset
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3126 Surgery, anesthesiology, intensive care, radiologyen_GB
dc.okm.discipline3126 Kirurgia, anestesiologia, tehohoito, radiologiafi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherElsevier
dc.publisher.countryNetherlandsen_GB
dc.publisher.countryAlankomaatfi_FI
dc.publisher.country-codeNL
dc.relation.articlenumber107402
dc.relation.doi10.1016/j.ejps.2025.107402
dc.relation.ispartofjournalEuropean Journal of Pharmaceutical Sciences
dc.relation.volume217
dc.source.identifierhttps://www.utupub.fi/handle/10024/195250
dc.titleLongitudinal monitoring of nanofibrillar cellulose hydrogel medical implants in mice using positron emission tomography
dc.year.issued2025

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
1-s2.0-S0928098725003999-main (1).pdf
Size:
6.87 MB
Format:
Adobe Portable Document Format